1. Home
  2. IRIX vs PRPH Comparison

IRIX vs PRPH Comparison

Compare IRIX & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • PRPH
  • Stock Information
  • Founded
  • IRIX 1989
  • PRPH 1989
  • Country
  • IRIX United States
  • PRPH United States
  • Employees
  • IRIX N/A
  • PRPH N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PRPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRIX Health Care
  • PRPH Health Care
  • Exchange
  • IRIX Nasdaq
  • PRPH Nasdaq
  • Market Cap
  • IRIX 16.5M
  • PRPH 17.7M
  • IPO Year
  • IRIX 1996
  • PRPH 1997
  • Fundamental
  • Price
  • IRIX $1.12
  • PRPH $0.33
  • Analyst Decision
  • IRIX
  • PRPH
  • Analyst Count
  • IRIX 0
  • PRPH 0
  • Target Price
  • IRIX N/A
  • PRPH N/A
  • AVG Volume (30 Days)
  • IRIX 172.5K
  • PRPH 15.4M
  • Earning Date
  • IRIX 08-12-2025
  • PRPH 08-13-2025
  • Dividend Yield
  • IRIX N/A
  • PRPH N/A
  • EPS Growth
  • IRIX N/A
  • PRPH N/A
  • EPS
  • IRIX N/A
  • PRPH N/A
  • Revenue
  • IRIX $49,744,000.00
  • PRPH $4,618,000.00
  • Revenue This Year
  • IRIX $9.61
  • PRPH $221.82
  • Revenue Next Year
  • IRIX N/A
  • PRPH N/A
  • P/E Ratio
  • IRIX N/A
  • PRPH N/A
  • Revenue Growth
  • IRIX 0.09
  • PRPH N/A
  • 52 Week Low
  • IRIX $0.78
  • PRPH $0.22
  • 52 Week High
  • IRIX $2.14
  • PRPH $3.00
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 42.12
  • PRPH 46.13
  • Support Level
  • IRIX $1.27
  • PRPH $0.28
  • Resistance Level
  • IRIX $1.34
  • PRPH $0.44
  • Average True Range (ATR)
  • IRIX 0.08
  • PRPH 0.04
  • MACD
  • IRIX -0.03
  • PRPH -0.00
  • Stochastic Oscillator
  • IRIX 10.85
  • PRPH 23.86

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

Share on Social Networks: